The venture was found in Europe in Spain. The leading representative office of defined Corporate Investor is situated in the Madrid.
The usual cause for the fund is to invest in rounds with 6 partakers. Despite the Grupo Genetrix, startups are often financed by Ysios Capital, Ventech, Roche Venture Fund. The meaningful sponsors for the fund in investment in the same round are Ysios Capital, Ventech, Roche Venture Fund.
Among the most successful fund investment fields, there are Pharmaceutical, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Cellerix. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - Spain.
The high activity for fund was in 2010. The higher amount of exits for fund were in 2011. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars.
Related Funds
Funds with similar focus
Fund Name | Location |
Bowater | Greenville, South Carolina, United States |
Growth and Transition Capital | - |
Kyushu Electric Power | Fukuoka, Fukuoka Prefecture, Japan |
Leapfrog Ventures | California, Menlo Park, United States |
Outcomes Fund | California, Los Angeles, United States |
Polybius Capital | Australia, New South Wales, Sydney |
Shijo | Japan, Koto |
Tribune Publishing | Chicago, Illinois, United States |
Visual China Group | Beijing, Beijing, China |
Zhuhai Huaying | China, Guangdong, Zhuhai |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Cellerix | $37M | 28 Jan 2010 | Madrid, Community of Madrid, Spain |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Cellerix | $37M | 28 Jan 2010 | Madrid, Community of Madrid, Spain |